FDA Inspection 1246559 — Isopure Corp.

Isopure Corp. — FEI 3013942511

The FDA completed an inspection of Isopure Corp. on August 15, 2024 in Louisville, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 15, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Louisville, KY (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures